help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GAUVREAU, G. M.
Right arrow Articles by O'BYRNE, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GAUVREAU, G. M.
Right arrow Articles by O'BYRNE, P. M.

Am. J. Respir. Crit. Care Med., Volume 156, Number 6, December 1997, 1738-1745

Effect of Regular Inhaled Albuterol on Allergen-induced Late Responses and Sputum Eosinophils in Asthmatic Subjects

G. M. GAUVREAU, M. JORDANA, R. M. WATSON, D. W. COCKCROFT, and P. M. O'BYRNE

Asthma Research Group, Departments of Medicine and Pathology, McMaster University, Hamilton; and Division of Respiratory Medicine, Department of Medicine Royal University Hospital, Saskatoon, Saskachewan, Canada

Treatment with inhaled beta 2-agonists immediately before allergen inhalation inhibits allergen-induced early, but not late asthmatic responses (LAR). By contrast, 2 wk treatment with inhaled albuterol increases airway responses to inhaled allergen. We examined the effects of regular albuterol treatment on allergen-induced increases in inflammatory cells in blood and induced sputum. Ten mild, stable allergic asthmatics inhaled albuterol (800 µg/day) or placebo for 7 d in a controlled, randomized, double-blind, crossover study. Allergen inhalation was performed 12 h after the final dose. Methacholine airway responsiveness and blood samples were analyzed before and 24 h after, and induced sputum was obtained before, 7 h and 24 h after allergen. Allergen significantly reduced methacholine PC20, increased blood eosinophil numbers, and numbers of sputum neutrophils, EG2 positive and metachromatic cells (p < 0.05), without significant differences between treatments. Albuterol treatment significantly increased the LAR compared to placebo treatment (p = 0.003) and significantly enhanced the number of sputum eosinophils (p = 0.009) and sputum ECP (p = 0.04) at 7 h but not 24 h post-allergen (p > 0.05). We conclude that regular use of inhaled albuterol significantly increases the LAR to inhaled allergen, in association with an increase in the number of sputum eosinophils and the release of ECP, suggesting albuterol increases the late response by increasing eosinophil influx into the airways.




This article has been cited by other articles:


Home page
 ThoraxHome page
C. Page
The {beta}2 receptor and airway hyper-responsiveness: are sensory nerves involved?
Thorax, September 1, 2009; 64(9): 738 - 739.
[Full Text] [PDF]

Home page
 ThoraxHome page
M Lommatzsch, Y Lindner, A Edner, K Bratke, M Kuepper, and J C Virchow
Adverse effects of salmeterol in asthma: a neuronal perspective
Thorax, September 1, 2009; 64(9): 763 - 769.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
B. T. Ameredes and W. J. Calhoun
(R)-Albuterol for Asthma: Pro [a.k.a. (S)-Albuterol for Asthma: Con].
Am. J. Respir. Crit. Care Med., November 1, 2006; 174(9): 965 - 969.
[Full Text] [PDF]

Home page
 ChestHome page
M. M. Kelly, J. Chakir, D. Vethanayagam, L.-P. Boulet, M. Laviolette, J. Gauldie, and P. M. O'Byrne
Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge.
Chest, September 1, 2006; 130(3): 741 - 753.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. Machida, H. Inoue, K. Matsumoto, M. Tsuda, S. Fukuyama, H. Koto, H. Aizawa, Y. Kureishi, N. Hara, and Y. Nakanishi
Activation of PI3K-Akt pathway mediates antiapoptotic effects of {beta}-adrenergic agonist in airway eosinophils
Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L860 - L867.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
S. R. Salpeter, T. M. Ormiston, and E. E. Salpeter
Meta-Analysis: Respiratory Tolerance to Regular {beta}2-Agonist Use in Patients with Asthma
Ann Intern Med, May 18, 2004; 140(10): 802 - 813.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Z. Callaerts-Vegh, K. L. J. Evans, N. Dudekula, D. Cuba, B. J. Knoll, P. F. K. Callaerts, H. Giles, F. R. Shardonofsky, and R. A. Bond
Effects of acute and chronic administration of {beta}-adrenoceptor ligands on airway function in a murine model of asthma
PNAS, April 6, 2004; 101(14): 4948 - 4953.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P.K. Jeffery, P. Venge, M.J. Gizycki, I. Egerod, R. Dahl, and P. Faurschou
Effects of salmeterol on mucosal inflammation in asthma: a placebo-controlled study
Eur. Respir. J., December 1, 2002; 20(6): 1378 - 1385.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. Leigh, D. Vethanayagam, M. Yoshida, R. M. Watson, T. Rerecich, M. D. Inman, and P. M. O'Byrne
Effects of Montelukast and Budesonide on Airway Responses and Airway Inflammation in Asthma
Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1212 - 1217.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. J. Hancox, P. Subbarao, D. Kamada, R. M. Watson, F. E. Hargreave, and M. D. Inman
beta 2-Agonist Tolerance and Exercise-induced Bronchospasm
Am. J. Respir. Crit. Care Med., April 15, 2002; 165(8): 1068 - 1070.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. E. Varner
The Increase in Allergic Respiratory Diseases : Survival of the Fittest?
Chest, April 1, 2002; 121(4): 1308 - 1316.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P.J. Barnes
Scientific rationale for inhaled combination therapy with long-acting {beta}2-agonists and corticosteroids
Eur. Respir. J., January 1, 2002; 19(1): 182 - 191.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. Jokic, V. A. Swystun, B. E. Davis, and D. W. Cockcroft
Regular Inhaled Salbutamol : Effect on Airway Responsiveness to Methacholine and Adenosine 5'-Monophosphate and Tolerance to Bronchoprotection
Chest, February 1, 2001; 119(2): 370 - 375.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
D R Taylor and R J Hancox
Interactions between corticosteroids and beta agonists
Thorax, July 1, 2000; 55(7): 595 - 602.
[Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. E. ALDRIDGE, R. J. HANCOX, D. ROBIN TAYLOR, J. O. COWAN, M. C. WINN, C. M. FRAMPTON, and G. IAN TOWN
Effects of Terbutaline and Budesonide on Sputum Cells and Bronchial Hyperresponsiveness In Asthma
Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1459 - 1464.
[Abstract] [Full Text]

Home page
 CMAJHome page
{beta}2-Agonists
Can. Med. Assoc. J., November 1, 1999; 161(90111): s28 - 31.
[Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
G. M. GAUVREAU, R. M. WATSON, and P. M. O'BYRNE
Kinetics of Allergen-Induced Airway Eosinophilic Cytokine Production and Airway Inflammation
Am. J. Respir. Crit. Care Med., August 1, 1999; 160(2): 640 - 647.
[Abstract] [Full Text]

Home page
 Pharmacol. Rev.Home page
M. A. Giembycz and M. A. Lindsay
Pharmacology of the Eosinophil
Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
G. M. GAUVREAU, R. M. WATSON, and P. M. O'BYRNE
Protective Effects of Inhaled PGE2 on Allergen-induced Airway Responses and Airway Inflammation
Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 31 - 36.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1997 American Thoracic Society 		  Red In Translatin